Praziquantel--its use, cost and possible development of resistance.
Kusel
J
J
Hagan
P
P
D000349:Africa; D000818:Animals; D000871:Anthelmintics / Q000191:economics / Q000494:pharmacology / Q000592:standards / Q000627:therapeutic use*; D002648:Child; D004351:Drug Resistance; D005260:Female; D006801:Humans; D010073:Oxamniquine / Q000627:therapeutic use; D011223:Praziquantel / Q000191:economics / Q000494:pharmacology / Q000592:standards / Q000627:therapeutic use*; D011247:Pregnancy; D011786:Quality Control; D012550:Schistosoma mansoni / Q000187:drug effects*; D012555:Schistosomiasis mansoni / Q000188:drug therapy*; D012556:Schistosomicides / Q000627:therapeutic use; D014236:Trichlorfon / Q000627:therapeutic use
D000871:Anthelmintics; D012556:Schistosomicides; D010073:Oxamniquine; D011223:Praziquantel; D014236:Trichlorfon